Shopping Cart
Remove All
Your shopping cart is currently empty
NKP608 is a selective and highly effective neurokinin-1 (NK-1) receptor antagonist with anticancer and antianxiety activities, inhibiting the proliferation of human colorectal cancer cells through the Wnt signaling pathway.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $199 | - | In Stock |
| Description | NKP608 is a selective and highly effective neurokinin-1 (NK-1) receptor antagonist with anticancer and antianxiety activities, inhibiting the proliferation of human colorectal cancer cells through the Wnt signaling pathway. |
| Targets&IC50 | HSP:13 nM (gerbil midbrain), HSP:2.6 nM (bovine retina), HSP:27 nM (rat striatum), IP1:2.6 nM |
| In vitro | NKP608 inhibited the binding of H-SP to bovine retina with an IC50 of 2.6 nM, and to rat striatum and gerbil midbrain membranes with IC50s of 27 and 13 nM. [5] In human astrocytoma cell (U-373) cultures NKP608 inhibited the SP induced increase in IP1 accumulation with an IC50 of 2.6 nM, indicating potent functional antagonism at the human receptor. [5] |
| In vivo | NKP608 (0.03, 0.1, 0.3, 1 or 3 mg/kg) was given orally 2, 5 or 24 h prior to the i.c.v. administration of 1 mg SPOMe. NKP608 dose-dependently attenuated SPOMe-induced hind foot thumping. [5] |
| Synonyms | NKP-608, NKP 608 |
| Molecular Weight | 619.99 |
| Formula | C31H24ClF6N3O2 |
| Cas No. | 177707-12-9 |
| Smiles | C([C@H]1N(C(=O)C2=CC(C(F)(F)F)=CC(C(F)(F)F)=C2)CC[C@H](NC(=O)C=3C4=C(N=CC3)C=CC=C4)C1)C5=CC=C(Cl)C=C5 |
| Relative Density. | 1.44 g/cm3 (Predicted) |
| Color | White |
| Appearance | Solid |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | H2O: Insoluble. DMSO: 80 mg/mL (129.04 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (5.32 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.